Biolosion
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Biolosion, covering 2026-04-01 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer [Phase 2]